检测血清孕酮及β-HCG对评估早孕先兆流产结局的价值分析

Value Analysis of Serum Progesterone and beta-HCG Detetction in Evaluating Outcome of Threatened Abortion of Early Pregnancy

目的分析检测血清孕酮及β-HCG对评估早孕先兆流产结局的价值。方法选取本院早孕先兆流产患者及健康孕妇作为样本,分别视之为观察组与对照组。采用全自动免疫分析仪,检测患者的各项指标。给予早孕先兆流产患者黄体酮+HCG治疗。结果观察组孕妇P(15.89±2.01)nmol/L、β-HCG(12647.69±433.69)mIU/mL。治疗后,孕妇流产率4.88%、死胎率2.44%,92.68%的孕妇,均未见不良妊娠结局,与对照组相比,无明显差异(P>0.05)。结论将血清孕酮及β-HCG应用到早孕先兆流产结局的评估中,可有效检出疾病。以检查结果为依据,给予孕妇药物治疗,能够有效改善妊娠结局。

Objective to analyze value of serum progesterone and beta-HCG detetction in evaluating outcome of threatened abortion of early pregnancy. Methods choose early pregnancy threatened abortion patients and healthy pregnant women as samples, treat them as observation and control group. Detect indicators of patients with automatic immune analyzer. Treat early pregnancy threatened abortion patients with progesterone ＋HCG. Results P value of pregnant women in observation group was（15.89±2.01） nmol/L, and beta-HCG was（12647.69±433.69） mIU/mL. After treatment, abortion rate of pregnant women was 4.88%, stillbirth rate was 2.44%, and 92.68% of pregnant women had no adverse pregnancy outcomes, difference showed no significance from control group,（P0.05）. Conclusion serum progesterone and beta-HCG can detect diseases effectively in evaluating outcome of threatened abortion of early pregnancy. Based on examination results, medication treatment can improve pregnancy outcome of pregnant women effectively.